The project includes the discovery of new drugs that target immunomodulatory pathways involved in cancer and infectious diseases. In the project, ZoBio’s proprietary fragment screening technology, TINS, will
The drug falls in the cardiovascular segment and the combined sales of all the strengths as per NDC was estimated at $301 million in 2007. This marks the
The approval is said to help Elekta deliver and install this advanced technology at new and existing customer sites in Japan. According to the company, Leksell Gamma Knife
Under the terms of the agreement, Emergent will acquire substantially all assets of Protein Sciences (PSC), including: FluBlok (trivalent recombinant hemagglutinin vaccine). FluBlok is a Phase III influenza
Based on the collective labor agreement signed on May 8, 2008 with its social partners, a total of 24 labor contracts will be terminated in a first phase
The study will evaluate DM-83s effectiveness at controlling blood sugar levels in type 2 diabetics after consuming a meal. The 20 patient trial will measure both changes in
Under the agreement, GVK Bio will receive an initial payment and will be eligible for success-based milestone payments. GVK Bio will be responsible for identifying drug candidates, which
The GSL-120 – which has already been shipped and installed at various customer locations – is said to be specifically designed for integration with the Applied Imaging CytoVision
The key objective of the study is to assess the clinical efficacy of an oral capsule formulation of iclaprim as step-down therapy in comparison with a full course
Currently, Mr Crotty is managing partner of CroBern Management Partnership, a healthcare investment and advisory firm. Previously, he served as president and CEO of CroBern, a healthcare consulting
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.